Sector: MedicalForest Laboratories, Inc. (NYSE: FRX)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 212 |
Technical : | 152 |
Performance : | 231 |
Overall: | 247 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 210 |
Technical : | 51 |
Performance : | 211 |
Overall: | 171 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 211 |
Technical : | 18 |
Performance : | 207 |
Overall: | 153 |
Number of Stocks: | 305 |
Headlines
- Wedgewood Pharmacy Compounds Thyroid Tablets During Manufacturer Backorder of Armour Thyroid Tablets
Nov 05, 2009 11:05 AM | FRX
- Options Intelligence Report: High Energy Rewards For Option Trader At RRI
Nov 03, 2009 02:25 PM | BNI, CAR, FRX, RRI, SWK, WFR
- Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation
Nov 02, 2009 09:52 PM | FRX
- Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
Oct 28, 2009 02:05 PM | FRX
- Forest Laboratories, Inc. Reports Fiscal Second Quarter 2010 Earnings Per Share of $0.61, Including a Net $0.24 Per Share Charge for One-Time Items
Oct 20, 2009 08:01 AM | AZN, FRX
- Forest Laboratories and Cypress Bioscience Announce Study Shows Patients Treated with Savella Experience Improvements in Pain and Physical Function
Oct 17, 2009 05:00 PM | CYPB, FRX
- TheFortuneFinacial.com Progressive Review on BDN, EXH, GME, CL, FRX and LMT
Oct 14, 2009 05:44 AM | BDN, CL, EXH, FRX, GME, LMT
- Pennsylvania Bio Adds Two New Members to Its Board of Directors
Oct 07, 2009 02:27 PM | ENDP, FRX
- Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 Second Quarter Earnings
Oct 05, 2009 08:00 AM | FRX
- Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Oct 02, 2009 09:06 AM | FRX
- The Business Diary
Oct 19, 2009 01:55 AM | AMGN, BA, FRX, LLY, MTB, NTRS
- IMS Health Cuts Pharma Growth Forecast
Apr 23, 2009 02:56 PM | FRX, GSK, MRK, PFE, RX, SGP
- Business This Week - Apr 20 2009 1:57AM
Apr 20, 2009 01:57 AM | AMGN, BAC, CAL, COP, DAL, FRX
- Forest Laboratories Receives FDA Approval for Lexapro
Mar 20, 2009 02:21 PM | FRX
- Forest, Cypress Revise Timing for Commercial Availability of Savella
Mar 06, 2009 10:49 AM | CYPB, FRX
- The Ticker - Feb 26 2009 8:51PM
Feb 26, 2009 08:51 PM | FRX, PCR
- Exxon Mobil Just May Be Mother of All Bellwethers
Jan 24, 2009 08:16 AM | FRX, SPW, T, TSCM, XOM
- Movers: Corning, Ambac, Lehman, Coca-Cola, Staples, ConAgra
Sep 04, 2008 10:54 AM | ABK, ALTR, CAG, COST, ETH, FHN
- AstraZeneca: Third Quarter and Nine Months Results 2009
Oct 29, 2009 09:57 AM | AZN, FRX, NKTR
- Pappas Ventures Names Eric Linsley Managing Partner
Sep 28, 2009 09:55 AM | FRX, JNJ
- Forest Laboratories, Inc. And Nycomed Announce a Conference Call to Review Publication of Daxas® Phase III Clinical Trial Results
Aug 27, 2009 06:53 PM | FRX
- Nycomed and Forest Laboratories to Collaborate on Daxas® (roflumilast) for COPD
Aug 10, 2009 07:03 AM | FRX
- Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD
Aug 10, 2009 07:01 AM | FRX
- Biotech Hot in July Driven By Positive Drug Data and Acquisitions
Aug 03, 2009 01:14 PM | EPIX, FRX, HGSI, OREX
- Forest Laboratories, Inc. Reports Fiscal First Quarter 2010 Earnings Per Share of $0.87
Jul 21, 2009 08:12 AM | FRX
- Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation
Jul 10, 2009 09:15 AM | FRX
- Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2010 First Quarter Earnings
Jul 06, 2009 09:01 AM | FRX
- Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
Jun 19, 2009 01:26 PM | FRX
- Form 4 CANDEE WILLIAM J III For: Aug 10 (10K)
Aug 11, 2009 01:33 PM
- Form 4 GOODMAN KENNETH E For: Aug 10 (10K)
Aug 11, 2009 01:33 PM
- Form 4 GOLDWASSER DAN L For: Aug 10 (10K)
Aug 11, 2009 01:33 PM
- Form 4 COHAN GEORGE S For: Aug 10 (10K)
Aug 11, 2009 01:32 PM
- Form 4 Basgoz Nesli For: Aug 10 (10K)
Aug 11, 2009 01:32 PM
- Form 4 SALANS LESTER B For: Aug 10 (10K)
Aug 11, 2009 01:31 PM
- Form 4 SOLOMON HOWARD For: Jul 08 (10K)
Jul 14, 2009 11:22 AM
- Form 4 FOREST LABORATORIES INC For: Jun 16 Filed by: CANDEE WILLIAM J III (10K)
Jun 17, 2009 01:43 PM
- Form 4 COHAN GEORGE S For: Jun 10 (10K)
Jun 11, 2009 12:46 PM
- Form 4 OLANOFF LAWRENCE S For: Jun 08 (10K)
Jun 10, 2009 05:15 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
FRX
|
Compare to S&P
|
| YTD |
8.64 %
|
-5.30 %
|
| 4 Weeks |
-2.88 %
|
-3.91 %
|
| 12 Weeks |
5.29 %
|
2.68 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -2.30 %
|
|
EPS Growth in Last Year: 6.25 %
|
|
Sales Growth in Last Quarter: 5.53 %
|
|
Sales Growth in Last Quarter: 7.20 %
|
|
